Evidence map›Paper›PMID 38907103›Full record

ArticleNature aging2024

Single-nucleus sequencing reveals enriched expression of genetic risk factors in extratelencephalic neurons sensitive to degeneration in ALS.

Francesco Limone, Daniel A Mordes, Alexander Couto, Brian J Joseph, Jana M Mitchell, Martine Therrien, Sulagna Dia Ghosh, Daniel Meyer, Yingying Zhang, Melissa Goldman and 8 more

Abstract read
In one paragraph

Article in Nature aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Decoding neurodegeneration one cell at a time.The Journal of clinical investigation · 2026
    Review
  12. Article
  13. Aberrant Splicing Signatures Underpin Oligodendrocyte Damage in ALS and Neuron Loss in FTD.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Francesco Limone *Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. francesco.limone@nyulangone.org.ORCID http://orcid.org/0000-0002-2482-8801
Daniel A Mordes *Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-8344-2140
Alexander CoutoDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Brian J JosephDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-9876-0021
Jana M MitchellDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Martine TherrienStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-3150-4052
Sulagna Dia GhoshDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-1833-7296
Daniel MeyerStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-4720-9891
Yingying ZhangDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Melissa GoldmanStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Laura BortolinStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Inma CobosDepartment of Pathology, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-2043-1890
Beth StevensStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Steven A McCarrollStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-6954-8184
Irena KadiuNeuroinflammation Focus Area, UCB Pharma, Braine-l'Alleud, Belgium.
Aaron BurberryDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Olli PietiläinenDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Kevin EgganDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. kevin.eggan@bmrn.com.

Funding

THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIAP50AG005134 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI SPERLING, REISA A. · 1985 to 2018
$42.1M
Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI SCOTT Loren POMEROY, MUSTAFA SAHIN · 2021 to 2026
$9.4M
Novel pathways in C9ORF72-associated ALS and dementiaK08NS104270 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MORDES, DANIEL ADAM · 2019 to 2023
$995k
NIA NIH HHS P50 AG005134NICHD NIH HHS P50 HD105351NINDS NIH HHS K08 NS104270
6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by a progressive loss of motor function linked to degenerating extratelencephalic neurons/Betz cells (ETNs). The reasons why these neurons are selectively affected remain unclear. Here, to understand the unique molecular properties that may sensitize ETNs to ALS, we performed RNA sequencing of 79,169 single nuclei from cortices of patients and controls. In both patients and unaffected individuals, we found significantly higher expression of ALS risk genes in THY1

Indexed as

Amyotrophic Lateral SclerosisNeuronsCell NucleusFemaleHumansMaleMicrogliaMiddle AgedNerve DegenerationOligodendrogliaRisk FactorsSequence Analysis, RNASingle-Cell Analysis

Identifiers

PMID38907103
PMCPMC11257952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.